Bolt Biotherapeutics BOLT
NASDAQ BOLT
$3.59 +0.13 (+3.75%)
As of: Sep 29, 2026 · 2:39 PM EDT

Bolt Biotherapeutics (BOLT) Total Current Liabilities (2020 - 2026)

Updated

Bolt Biotherapeutics (BOLT) posted Total Current Liabilities of $7.87 million for Q2 2026, down 36.1% from $12.31 million a year earlier but up 7.1% from the prior quarter.

Analysis

Bolt Biotherapeutics (BOLT) Total Current Liabilities (2020 - 2026) Analysis & Trends

At the end of FY2025, Bolt Biotherapeutics' Total Current Liabilities came in at $8.44 million, down 46.8% from FY2024.

  • Annual Total Current Liabilities has declined for three consecutive years, with a five-year compound annual growth rate of -5.6% (FY2020 to FY2025).
  • In prior years, Bolt Biotherapeutics' Total Current Liabilities was $15.86 million in FY2024 (-22.5%), $20.46 million in FY2023 (-11.5%), $23.12 million in FY2022 (+8.4%) and $21.33 million in FY2021 (+89.3%).
  • Quarterly Total Current Liabilities has run from a low of $7.34 million in Q1 2026 to a high of $24.17 million in Q3 2022 over five years.
  • On a year-over-year basis, Total Current Liabilities has declined in each of the last eight quarters, with an average decline of 31.2% over the last eight quarters.
  • The strongest year-over-year quarter for Total Current Liabilities in the past five years was Q4 2021, with growth of 89.3%; the weakest was Q4 2025, with a decline of 46.8%.
  • According to Business Quant data, Total Current Liabilities for the three prior quarters was $7.34 million (Q1 2026), $8.44 million (Q4 2025) and $9.97 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 54.90 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 41.64 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 27.73 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 31.75 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -31.55 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 25.50 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 11.02 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 32.65 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 3.94 Bn
10 Bolt Biotherapeutics 6.88 Mn 6.88 Mn - 7.87 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 7.87 Mn
Mar 31, 2026 7.34 Mn
Dec 31, 2025 8.44 Mn
Sep 30, 2025 9.97 Mn
Jun 30, 2025 12.31 Mn
Mar 31, 2025 13.56 Mn
Dec 31, 2024 15.86 Mn
Sep 30, 2024 18.08 Mn
Jun 30, 2024 17.90 Mn
Mar 31, 2024 16.72 Mn
Dec 31, 2023 20.46 Mn
Sep 30, 2023 18.75 Mn
Jun 30, 2023 17.62 Mn
Mar 31, 2023 16.25 Mn
Dec 31, 2022 23.12 Mn
Sep 30, 2022 24.17 Mn
Jun 30, 2022 18.62 Mn
Mar 31, 2022 19.31 Mn
Dec 31, 2021 21.33 Mn
Sep 30, 2021 23.70 Mn
API Access

Bolt Biotherapeutics Total Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=BOLT&period=max&api_key=YOUR_API_KEY